Anti-inflammatories may relieve pain in the short term, but blocking inflammation can lead to longer-term chronic pain, a new study reports.
By the time most of us hit our 40s, our close-up vision starts to decline and we develop presbyopia. A new eye drop called Vuity claims to alleviate the symptoms of presbyopia, allowing people to gain clearer vision without the need for glasses or surgery. Researchers examine the potential benefits of using Vuity for people with presbyopia.
Researchers identify the mechanisms behind tricyclic antidepressants' ability to help relieve nerve pain.
Zebrafish study finds antibiotics can have detrimental effects on the descendants of those exposed to them, including weaker immune systems.
Sulthiame, a CA inhibitor drug, reduced the number of breathing pauses and promoted oxygenation during the night in sufferers of obstructive sleep apnea.
Legalized marijuana for recreational use reduces the demand for prescription medications, a new study reveals. Researchers found the volume of medical prescriptions for pain, sleep disorders, anxiety, and some neurological conditions declined significantly when recreational marijuana was legalized.
Researchers say older adults who feel lonely are twice as likely to use opioids to control pain, and 2.5 times more likely to be prescribed anti-anxiety medications and sedatives than those who have a more socially active lifestyle.
Two medications commonly used to treat inflammation and HIV infection have been repurposed in the fight against COVID-19. Researchers found combined cepharanthine/nelfinavir therapy can hasten the clearance of coronavirus infection from a person's lungs in as little as 4.9 days. Cepharanthine hindered the entry of SARS_CoV_2 into cells, preventing the virus from binding to a protein on the cell membrane it uses as a gateway. Nelfinavir prevented the virus from replicating inside cells by inhibiting a protein the virus relies on for replication.
Genetically engineering botulinum toxin could help advance new treatments for everything from neurodegenerative disorders to cytokine storms.
A new machine-learning algorithm is assisting researchers to determine which existing drugs can be repurposed effectively for other conditions.
Dexamethasone, an inexpensive steroid, reduced death by one-third in ventilated COVID-19 patients, and by one fifth in patients receiving oxygen for severe coronavirus symptoms. Preliminary findings suggest one death per eight patients ventilated could be prevented by administering dexamethasone.
Famotidine (Pepcid AC), an over-the-counter medication used to treat indigestion, shows promise as a potential treatment for COVID-19.
